ASK REDCHAT ANYTHING ABOUT AN2 THERAPEUTICS, INC.
AN2 Therapeutics, Inc. (NASDAQ: ANTX)
Listen to this Section
$3.93
-0.2400
(
-5.76% )
63.2K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Market Data
|
| Open |
$3.93 |
| Previous Close |
$4.17 |
| Volume |
63.2K |
| Market Cap |
$151.27M |
| Day Range |
$3.93 - $4.19 |
| 52 Week Range |
$1.00 - $6.91 |
| Shares Outstanding |
36.02M |
| Change % |
-5.76% |
| Net Change |
▼ -0.2400 |
| Insider Ownership |
-0.18% |
| Exchange |
NASDAQ |
| Sector | Miscellaneous |
| Industry | None |
| IPO Year | 2022 |
| Country | United States |
| Underwriter | TD Cowen, Leerink Partners, Evercore ISI, Oppenheimer & Co., more |
Insider Ownership Transactions
Total Amount Purchased:
-1,219,102.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-07-12 |
Sale |
-60000.00 |
Eizen Joshua M |
| 2024-06-21 |
Sale |
-64503.00 |
Spigelman Melvin K |
| 2024-06-21 |
Sale |
-64503.00 |
Marks Gilbert Lynn |
| 2024-06-21 |
Sale |
-64503.00 |
Zakrzewski Joseph S |
| 2024-06-21 |
Sale |
-64503.00 |
Aziz Kabeer |
| 2024-06-21 |
Sale |
-64503.00 |
Martin Patricia A. |
| 2024-06-21 |
Sale |
-64503.00 |
Wong Stephanie |
| 2024-06-21 |
Sale |
-64503.00 |
FitzPatrick Margaret M |
| 2024-06-21 |
Sale |
-64503.00 |
Readnour Robin Shane |
| 2024-03-18 |
Sale |
-27500.00 |
Day Lucy |
SEC Filings
| Form Type |
Description |
Pages |
Date |
| 10-q |
Quarterly Reports |
60 |
Nov 12, 2025 |
| 8-k |
8K-related |
11 |
Nov 12, 2025 |
| 4 |
Insider transactions |
1 |
Nov 06, 2025 |
| 4 |
Insider transactions |
1 |
Nov 06, 2025 |
| 4 |
Insider transactions |
1 |
Oct 14, 2025 |
| 4 |
Insider transactions |
1 |
Oct 14, 2025 |
| 4 |
Insider transactions |
1 |
Oct 14, 2025 |
| 8-k |
8K-related |
11 |
Aug 12, 2025 |
| 10-q |
Quarterly Reports |
61 |
Aug 12, 2025 |
| 4 |
Insider transactions |
1 |
Jul 11, 2025 |